• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Updated: Greener pastures lure Delcath and Osteologix, more details emerge

Updated: Greener pastures lure Delcath and Osteologix, more details emerge

August 9, 2011 By MassDevice staff

Updated 8/8/2011 7:15 p.m.

Osteologix
Ireland
Delcath

Delcath Systems Inc. (NSDQ:DCTH) and Osteologix Holdings plc (PINK:OLGXF) planted roots in Ireland this month.

New York-based chemotherapy device maker Delcath landed a grant from the Irish government to support training of marketing, sales and logistics teams at its new European operations center in Galway, Ireland, under Delcath Systems Limited.

"The region is the European home for many international medical device and pharmaceutical companies attracted by its pro-business environment, efficient tax system, logistics and cost advantages, and deep pool of qualified management talent," president & CEO Eamonn Hobbs said in prepared remarks.

Delcath has a 20,000 square-foot building picked out in the IDA Business Mark, where recruiting is already underway, company spokesperson Steve DiMattia told MassDevice. Initial staffing calls for up to 35 marketing, sales and logistics personnel, and recruiting will continue for the next six to 12 months.

The facility should open in Q4 2011, DiMattia told us.

The overseas regulatory process has been a much easier one to traverse, and the company’s flagship isolated chemotherapy delivery system, Chemosat, won CE Mark approval in the European Union in April, Hobbs told MassDevice in June.

"We expect to have regulatory approval in countries in Asia, South America, Central America and Canada, the Middle East and Africa starting in 2012," he said. "We should have regulatory approval in virtually all the countries by the end of 2013."

Shares of Delcath stock were trading at $3.21 at midday today, a 14 percent decrease from yesterday’s close at $3.75.

Osteoporosis therapy company Osteologix moved its corporate headquarters to Ireland, having shut down its Glen Allen, Va., facility entirely. It also dissolved parent company Osteologix Inc. (OTC:OLGX) and deregistered from the NASDAQ stock exchange, per announcements made in December.

OLGXF stock opened at 26 cents per share today, after OLGX closed at that price on July 26.

Osteologix hopes to minimize corporate overhead, maximize licensing agreements with research groups and seek out development partners in the U.S., according to a press release.

Filed Under: News Well, Oncology, Pharmaceutical, Wall Street Beat Tagged With: Delcath Systems Inc., Osteologix

More recent news

  • Comphya raises CHF 7.5 million for neurostim to treat ED
  • Fujifilm launches intelligent automation features for digital radiography
  • Integer appoints former iRhythm CEO to board
  • MMI debuts robotic surgery instruments, digital surgery platform
  • Synchrony Medical wins FDA nod for airway clearance system

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy